International Normalized Ratio as a Screening Test for Assessment of Anticoagulant Activity for Patients Treated With Rivaroxaban or Apixaban: A Pilot Study

Introduction: In patients treated with direct oral anti activated factor X (anti-FXa) anticoagulants such as apixaban and rivaroxaban, there are several emergency and non-emergency conditions in which anticoagulation activity should be measured. The validity of the common global clotting tests, prot...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Front Pharmacol
Main Authors: Ofek, Fanny, Barchel, Dana, Perets, Nofar, Ziv-Baran, Tomer, Mahajna, Ahmad, Filipovich-Rimon, Talia, Garach-Jehoshua, Osnat, Berlin, Maya, Berkovitch, Matitiahu
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2019
Assuntos:
Pharmacology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6792346/
https://ncbi.nlm.nih.gov/pubmed/31649541
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2019.01177
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares